/
Log inGet free API keyAccount
Menu
InvestorsCompaniesFit CheckerDocsPricingGet free API key

Companies / Milestone Pharmaceuticals

Milestone Pharmaceuticals

United States

Milestone Pharmaceuticals develops treatments for self-administration outside the emergency department or healthcare setting for people with acute episodes of paroxysmal supraventricular tachycardia and other episodic cardiovascular conditions.

Healthcare & Biotech

Milestone Pharmaceuticals, based in United States, has 2 investors on file, among them Boxer Capital and Pappas Capital. Its site was last checked 7 Nov 2026: site answers.

milestonepharma.com

SEC Form D filings

4 filings
$80.0M sold26 Oct 2018$6.9M sold25 Jul 2017$3.8M sold of $9.4M offered15 Jun 2015$596K sold14 Jun 2011

Filed by Milestone Pharmaceuticals Inc. with the SEC. A Form D reports a private offering; it is not a priced round.

Investors

2 investors on file
InvestorEvidenceType
Boxer CapitalPortfolio pageVenture capital
Pappas CapitalPortfolio pageVenture capital

More from Boxer Capital

40 companies on its checked portfolio

Its portfolio leans to Healthcare & Biotech (90%), AI & Machine Learning (5%), Fintech (3%).

Aligos TherapeuticsAligos Therapeutics develops therapies for liver and viral diseasesAvidity BiosciencesAvidity Biosciences is developing RNA therapeutics for rare muscle dis…BioAtlaBioAtla develops novel therapeutics with improved therapeutic index th…Boundless BioBoundless Bio develops therapies for patients with intractable oncogen…Cabaletta BioCabaletta Bio develops T cell therapies to treat autoimmune diseases

See Boxer Capital's full profile · Who invests alongside it

More from Pappas Capital

39 companies on its checked portfolio

Its portfolio leans to Healthcare & Biotech (71%), AI & Machine Learning (16%), Education (2%).

4D Molecular TherapeuticsThe company invents and develops genetic medicines with proprietary cu…Aer TherapeuticsAer Therapeutics develops a therapy to liquify mucus plugs in the lung…AktisAktis Oncology develops targeted alpha-based radiopharmaceuticals for …Altay TherapeuticsAltay Therapeutics develops small molecules to address serious disease…BioAtlaBioAtla develops novel therapeutics with improved therapeutic index th…

See Pappas Capital's full profile · Who invests alongside it

A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data

Free account · no card

Get Milestone Pharmaceuticals and its investors as data

Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Boxer Capital adds a company.

Work email, sign-in link by email. Already have an account? Log in
Your API keyRead the docs
  • Ask AI5 plain-English investor searches a day
  • Full listsEvery portfolio row and two-firm overlap
  • API and MCP100 REST or MCP calls a month, one key
  • AlertsFollow 5 investors for portfolio and fund changes
VCinfo API
$ curl -H "X-API-Key: YOUR_KEY" \
  https://api.vcinfo.io/v1/companies/milestonepharma.com/investors

# also
GET /v1/companies/milestonepharma.com
GET /v1/companies/milestonepharma.com/news
The same data as an MCP server for Claude, Cursor and other AI tools. Set up MCP · Docs · Pricing